Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12. September 2024 07:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12. September 2024 01:00 ET
|
Genespire
PRESS RELEASE Genespire appoints Karen Aiach-Pignet as Chief Executive Officer Karen’s appointment bolsters Genespire’s position as a leader in in-vivo lentiviral gene therapy Milan, Italy, 12...